Expression of suppressor of cytokine signaling 1 in the peripheral blood of patients with idiopathic pulmonary fibrosis

Chinese Medical Journal

Volumn 127, Issue 11, 2014, Pages 2117-2120

  Bao, Zhi Yao ^a,b   Zhang, Qiu Rui ^a   Wan, Huan Ying ^a   He, Ping ^a   Zhou, Xin ^b   Zhou, Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Idiopathic pulmonary fibrosis; Interleukin 4; Suppressor of cytokine signaling

Indexed keywords

INTERLEUKIN 4; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84901648140     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20133038     Document Type: Article

References (18)

1. Nalysnyk L, Cid-Ruzafa J, Rotella P, Esser D. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur Respir Rev 2012; 21: 355-361.
2. Harari S, Caminati A. IPF: new insight on pathogenesis and treatment. Allergy 2010; 65: 537-553.
3. Strieter RM, Keane MP. Innate immunity dictates cytokine polarization relevant to the development of pulmonary fibrosis. J Clin Invest 2004; 114: 165-168.
4. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7: 454-465.
5. Yoshimura A, Suzuki M, Sakaguchi R, Hanada T, Yasukawa H. SOCS, infammation, and autoimmunity. Front Immunol 2012; 3: 20.
6. Fenner JE, Starr R, Cornish AL, Zhang JG, Metcalf D, Schreiber RD, et al. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol 2006; 7: 33-39.
7. Shoda H, Yokoyama A, Nishino R, Nakashima T, Ishikawa N, Haruta Y, et al. Overproduction of collagen and diminished SOCS-1 expression are causally linked in fibroblasts from idiopathic pulmonary fbrosis. Biochem Biophys Res Commun 2007; 353: 1004-1010.
8. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
9. Cao H, Pan M, Kang Y, Xia Q, Li X, Zhou M, et al. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody. Arthritis Care Res (Hoboken) 2012; 64: 1602-1610.
10. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172: 488-493.
11. Borchers AT, Chang C, Keen CL, Gershwin ME. Idiopathic pulmonary fibrosis-an epidemiological and pathological review. Clin Rev Allergy Immunol 2011; 40: 117-134.
12. Nakashima T, Yokoyama A, Onari Y, Shoda H, Haruta Y, Hattori N, et al. Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis. J Allergy Clin Immunol 2008; 121: 1269-1276.
13. Xu J, Mora AL, LaVoy J, Brigham KL, Rojas M. Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet. Am J Physiol Lung Cell Mol Physiol 2006; 291: L658-L667.
14. Jakubzick C, Kunkel SL, Puri RK, Hogaboam CM. Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fbrosis. Immunol Res 2003; 30: 339-349.
15. Jakubzick C, Choi ES, Joshi BH, Keane MP, Kunkel SL, Puri RK, et al. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J Immunol 2003; 171: 2684-2693.
16. Willis BC, duBois RM, Borok Z. Epithelial origin of myofbroblasts during fibrosis in the lung. Proc Am Thorac Soc 2006; 3: 377-382.
17. Hisatomi K, Mukae H, Sakamoto N, Ishimatsu Y, Kakugawa T, Hara S, et al. Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells. BMC Pulm Med 2012; 12: 24.
18. Qian YR, Zhang QR, Cheng T, Wan HY, Zhou M. RNA interference-mediated silencing of SOCS-1 via lentiviral vector promotes apoptosis of alveolar epithelial cells in vitro. Mol Med Report 2012; 5: 452-456.